Science Explorer Interactive view Map
Company · Cambridge · United States

Spero Therapeutics (United States)

sperotherapeutics.comROR OpenAlex
Research works
83
▲ 1145% vs 2013–17
Citations
1.8k
21.3 per fractional work
Top-10% rate
18.4%
record average 16.5%
Open access
84%
world 28%

Not ranked overall: Spero Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 4.01× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 5.38× its world share, 1 worksImmunology and Micro…Neuroscience: 0.10× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.51× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.32× its world share, 0 worksChemistryComputer Science: 0.04× its world share, 0 worksComputer ScienceEngineering: 0.07× its world share, 0 worksEngineeringEnvironmental Science: 0.47× its world share, 1 worksEnvironmental ScienceHealth Professions: 0.96× its world share, 1 worksHealth ProfessionsMedicine: 3.23× its world share, 16 worksMedicineVeterinary: 5.45× its world share, 0 worksVeterinaryEconomics, Econometrics and Finance: 0.74× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 5.5×. Every wedge is a field page.

Which keywords describe research at Spero Therapeutics (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Antimicrobial Resistance, Antibiotic Resistance, ESKAPE Pathogens, Multidrug-Resistant Bacteria, Antibiotic Pharmacokinetics, Critically Ill Patients and Diagnosis.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 24 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 24 words, with their numbers
  1. Epidemiology8▲ 8.2×10 topics
  2. Antimicrobial Resistance8▲ 150×3 topics
  3. Antibiotic Resistance7▲ 66×4 topics
  4. ESKAPE Pathogens4▲ 266×1 topic
  5. Multidrug-Resistant Bacteria4▲ 266×1 topic
  6. Antibiotic Pharmacokinetics4▲ 514×1 topic
  7. Critically Ill Patients4▲ 514×1 topic
  8. Diagnosis4▲ 15×5 topics
  9. Treatment4▲ 11×4 topics
  10. Drug Resistance3▲ 42×3 topics
  11. Treatment Guidelines3▲ 55×2 topics
  12. Catheter-Associated Infections3▲ 326×1 topic
  13. Urinary Tract Infections3▲ 258×1 topic
  14. Immune Response2▲ 14×2 topics
  15. Vaccine2▲ 20×2 topics
  16. Mycobacterium tuberculosis2▲ 125×1 topic
  17. Tuberculosis2▲ 133×1 topic
  18. Mycobacterium avium1▲ 161×1 topic
  19. Nontuberculous Mycobacteria1▲ 161×1 topic
  20. Antiretroviral Therapy1▲ 31×4 topics
  21. Clinical Practice Guidelines1▲ 8.0×3 topics
  22. Infectious Diseases1▲ 13×2 topics
  23. Pediatric1▲ 70×1 topic
  24. Urinary Tract Infection1▲ 104×1 topic

Which research topics does Spero Therapeutics (United States) publish most on?

By volume in 2022–2025: Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy, Urinary Tract Infections Management and Tuberculosis Research and Epidemiology.

Antibiotic Resistance in…4Antibiotic Resistance in Bacteria: 4 fractional worksAntibiotics Pharmacokine…4Antibiotics Pharmacokinetics and Efficacy: 4 fractional worksUrinary Tract Infections Management: 3 fractional worksTuberculosis Research and Epidemiology: 2 fractional worksMycobacterium research and diagnosis: 1 fractional worksPediatric Urology and Ne…1Pediatric Urology and Nephrology Studies: 1 fractional worksPneumonia and Respiratory Infections: 1 fractional worksAntibiotic Use and Resistance: 1 fractional worksFibroblast Growth Factor Research: 0 fractional worksDrug Transport and Resistance Mechanisms: 0 fractional works
Molecular MedicinePharmacologyEpidemiologyInfectious Diseases4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Antibiotic Resistance in Bacteria Molecular Medicine 4 works
  2. 2 Antibiotics Pharmacokinetics and Efficacy Pharmacology 4 works
  3. 3 Urinary Tract Infections Management Epidemiology 3 works
  4. 4 Tuberculosis Research and Epidemiology Infectious Diseases 2 works
  5. 5 Mycobacterium research and diagnosis Epidemiology 1 works
  6. 6 Pediatric Urology and Nephrology Studies Pediatrics, Perinatology and Child Health 1 works
  7. 7 Pneumonia and Respiratory Infections Epidemiology 1 works
  8. 8 Antibiotic Use and Resistance Applied Microbiology and Biotechnology 1 works
  9. 9 Fibroblast Growth Factor Research Molecular Biology 0 works
  10. 10 Drug Transport and Resistance Mechanisms Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available84.1%not open15.9%

World: 28% of research is openly available.

with international co-authors10.2%domestic only89.8%

World: 19% is written across borders.

How has Spero Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 1145% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.